The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes.

The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes.

MicroRNAs (miRNAs) are involved in post-transcriptional regulation of gene expression through binding to messenger RNAs (mRNA) thereby promoting mRNA degradation or altered translation. A single-nucleotide polymorphism (SNP) located within a miRNA-binding site could thus alter mRNA translation and i...

Bibliografske podrobnosti
Main Authors:	Teo, M, Landi, D, Taylor, C, Elliott, F, Vaslin, L, Cox, D, Hall, J, Landi, S, Bishop, D, Kiltie, A
Format:	Journal article
Jezik:	English
Izdano:	2012

Podobne knjige/članki

DNA repair gene XRCC1 polymorphisms and bladder cancer risk
od: Sak, S, et al.
Izdano: (2007)

MRE11 variants as predictive markers of radiotherapy response in muscle invasive bladder cancer
od: Teo, M, et al.
Izdano: (2012)

DNA repair gene <it>XRCC1 </it>polymorphisms and bladder cancer risk
od: Bishop D Timothy, et al.
Izdano: (2007-04-01)

Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk.
od: Sak, S, et al.
Izdano: (2006)

Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.
od: Stern, M, et al.
Izdano: (2009)

Molecular epidemiology of DNA repair genes in bladder cancer.
od: Kiltie, A
Izdano: (2009)

DNA repair gene XPC polymorphisms, smoking, occupational exposures and the risk of bladder transitional cell carcinoma
od: Sak, S, et al.
Izdano: (2005)

Functional assays to determine the significance of two common XPC 3'UTR variants found in bladder cancer patients.
od: Qiao, B, et al.
Izdano: (2011)

MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.
od: Choudhury, A, et al.
Izdano: (2010)

Using gene polymorphisms to assess bladder cancer risk: progress and challenges.
od: Kiltie, A
Izdano: (2012)

Using gene polymorphisms to assess bladder cancer risk: Progress and challenges
od: Kiltie, A
Izdano: (2012)

Functional assays to determine the significance of two common <it>XPC </it>3'UTR variants found in bladder cancer patients
od: Bishop D, et al.
Izdano: (2011-06-01)

Analysis of variants in DNA damage signalling genes in bladder cancer
od: Choudhury, A, et al.
Izdano: (2008)

Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer
od: Teo, M, et al.
Izdano: (2014)

High MRE11 expression in muscle invasive bladder cancer is predictive of improved cause-specific survival following radical radiotherapy compared to surgery
od: Teo, T, et al.
Izdano: (2010)

In vitro functional effects of XPC gene rare variants from bladder cancer patients.
od: Qiao, B, et al.
Izdano: (2011)

Common predisposition alleles for moderately common cancers: bladder cancer.
od: Kiltie, A
Izdano: (2010)

Single Nucleotide Polymorphisms in MicroRNA Binding Sites: Implications in Colorectal Cancer
od: Panchalee Bhaumik, et al.
Izdano: (2014-01-01)

RAD51: A DNA repair target for increasing the therapeutic potential in bladder cancer
od: Choudhury, A, et al.
Izdano: (2005)

APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer.
od: Sak, S, et al.
Izdano: (2005)

The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder.
od: Sak, S, et al.
Izdano: (2005)

MRE11 as a predictive biomarker of outcome following radiotherapy in bladder cancer
od: Walker, AK, et al.
Izdano: (2019)

Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer.
od: Choudhury, A, et al.
Izdano: (2011)

Gemcitabine as a Chemoradiosensitiser in Bladder Cancer
od: Kerr, M, et al.
Izdano: (2012)

Mechanisms of microRNA action in rectal cancer radiotherapy
od: Lili Zhu, et al.
Izdano: (2022-09-01)

Single nucleotide polymorphisms at the microRNA-binding site of KIAA0423 are associated with colorectal cancer
od: Yue Zhao, et al.
Izdano: (2016-11-01)

Predictive Biomarkers for Gemcitabine as a Chemoradiosensitizer in Bladder Cancer
od: Kerr, M, et al.
Izdano: (2012)

A multicentre NCRI phase II study of hypofractionated conformal radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer
od: Choudhury, A, et al.
Izdano: (2010)

Utility of bladder-sparing therapy vs radical cystectomy for muscle-invasive bladder cancer
od: Efstathiou, J, et al.
Izdano: (2018)

Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer
od: A. Hunt, et al.
Izdano: (2020-11-01)

MicroRNA related polymorphisms and breast cancer risk.
od: Sofia Khan, et al.
Izdano: (2014-01-01)

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer
od: Miah, S, et al.
Izdano: (2012)

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer.
od: Miah, S, et al.
Izdano: (2012)

Imatinib radiosensitizes bladder cancer by targeting homologous recombination.
od: Qiao, B, et al.
Izdano: (2013)

DNA double strand break repair in human bladder cancer is error prone and involves microhomology-associated end-joining.
od: Bentley, J, et al.
Izdano: (2004)

Comparison of treatment outcome for radical surgery versus radical radiotherapy for invasive bladder cancer treated in a UK specialist treatment centre
od: Kotwal, S, et al.
Izdano: (2007)

Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center.
od: Kotwal, S, et al.
Izdano: (2008)

Diagnostic Value of Combination of MicroRNA-192 in Urinary Sediment and B-Ultrasound for Bladder Cancer
od: Fuquan Jiang PhD, et al.
Izdano: (2020-02-01)

URINARY MICRORNA IN BLADDER CANCER - A POTENTIAL DIAGNOSTIC TOOL
od: Miah, S, et al.
Izdano: (2011)

Haploinsufficiency of Tumor Suppressor Genes is Driven by the Cumulative Effect of microRNAs, microRNA Binding Site Polymorphisms and microRNA Polymorphisms: An In silico Approach
od: Mayakannan Manikandan, et al.
Izdano: (2012-08-01)